Detalles de la búsqueda
1.
Impact of biochemical failure classification on clinical outcome: a secondary analysis of Radiation Therapy Oncology Group 9202 and 9413.
Cancer
; 121(6): 844-52, 2015 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25410885
2.
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results.
Nat Med
; 30(4): 1013-1022, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38538867
3.
GRT-R910: a self-amplifying mRNA SARS-CoV-2 vaccine boosts immunity for ≥6 months in previously-vaccinated older adults.
Nat Commun
; 14(1): 3274, 2023 06 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37280238
4.
Impact of marital status and race on outcomes of patients enrolled in Radiation Therapy Oncology Group prostate cancer trials.
Support Care Cancer
; 20(6): 1317-25, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21720747
5.
Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results.
Nat Med
; 28(8): 1619-1629, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35970920
6.
Protein kinase A RI-alpha predicts for prostate cancer outcome: analysis of radiation therapy oncology group trial 86-10.
Int J Radiat Oncol Biol Phys
; 71(5): 1309-15, 2008 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18455330
7.
A descriptive analysis of postimplant dosimetric parameters from Radiation Therapy Oncology Group P0019.
Brachytherapy
; 5(4): 239-43, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-17118317
8.
A tissue biomarker-based model that identifies patients with a high risk of distant metastasis and differential survival by length of androgen deprivation therapy in RTOG protocol 92-02.
Clin Cancer Res
; 20(24): 6379-88, 2014 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25294917
9.
Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: an analysis of the Radiation Therapy Oncology Group.
Int J Radiat Oncol Biol Phys
; 82(1): 425-34, 2012 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20980108
10.
A phase II comparative study of gross tumor volume definition with or without PET/CT fusion in dosimetric planning for non-small-cell lung cancer (NSCLC): primary analysis of Radiation Therapy Oncology Group (RTOG) 0515.
Int J Radiat Oncol Biol Phys
; 82(1): 435-41.e1, 2012 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21075551
11.
Acute and late toxicity after dose escalation to 82 GyE using conformal proton radiation for localized prostate cancer: initial report of American College of Radiology Phase II study 03-12.
Int J Radiat Oncol Biol Phys
; 81(4): 1005-9, 2011 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20932675
12.
Impact of ultrahigh baseline PSA levels on biochemical and clinical outcomes in two Radiation Therapy Oncology Group prostate clinical trials.
Int J Radiat Oncol Biol Phys
; 80(2): 445-52, 2011 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20615632
13.
Phase I/II trial of a COX-2 inhibitor with limited field radiation for intermediate prognosis patients who have locally advanced non-small-cell lung cancer: radiation therapy oncology group 0213.
Clin Lung Cancer
; 12(2): 125-30, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21550559
14.
Impact of gender, partner status, and race on locoregional failure and overall survival in head and neck cancer patients in three radiation therapy oncology group trials.
Int J Radiat Oncol Biol Phys
; 81(3): e101-9, 2011 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21549515
15.
Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer.
Int J Radiat Oncol Biol Phys
; 81(1): 77-84, 2011 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20800380
16.
Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214.
J Clin Oncol
; 29(3): 272-8, 2011 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-21135270
17.
Older age predicts decreased metastasis and prostate cancer-specific death for men treated with radiation therapy: meta-analysis of radiation therapy oncology group trials.
Int J Radiat Oncol Biol Phys
; 81(5): 1293-301, 2011 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21458924
18.
Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis.
J Clin Oncol
; 29(3): 279-86, 2011 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-21135267
19.
Timing of salvage hormonal therapy in prostate cancer patients with unfavorable prognosis treated with radiotherapy: a secondary analysis of Radiation Therapy Oncology Group 85-31.
Int J Radiat Oncol Biol Phys
; 78(5): 1301-6, 2010 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20356687
20.
Baseline serum testosterone in men treated with androgen deprivation therapy and radiotherapy for localized prostate cancer.
Int J Radiat Oncol Biol Phys
; 78(5): 1314-22, 2010 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20378270